CIK 0001818844 · Non-accelerated filer<br>Smaller reporting company
Dogwood Therapeutics, Inc.
Sign in to watch- Ticker
- DWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 854314201
- Phone
- 8666208655
- Business address
- 44 MILTON AVENUE, ALPHARETTA, GA, 30009
- Former names
- Virios Therapeutics, Inc., Virios Therapeutics, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-28 | Pridgen William Director | Option exercise · Warrant to Purchase Common Stock | −801 | 0 | ||
| 2021-01-28 | Keefer David R Director | Option exercise | +1,602 | $7.80 | $12K | 7,808 |
| 2021-01-28 | Keefer David R Director | Option exercise · Warrant to Purchase Common Stock | −1,602 | 0 | ||
| 2021-01-11 | Duncan Gregory Scott Chief Executive Officer | Grant or award · Stock Option (right to buy) | +21,796 | 435,921 | ||
| 2021-01-11 | Grosswald Ralph VP of Finance | Grant or award · Stock Option (right to buy) | +209 | 41,621 | ||
| 2021-01-11 | Walsh Angela VP of Finance | Grant or award · Stock Option (right to buy) | +209 | 41,621 | ||
| 2021-01-06 | Duncan Gregory Scott Chief Executive Officer | Option exercise | +801 | $7.80 | $6K | 3,904 |
| 2021-01-06 | Duncan Gregory Scott Chief Executive Officer | Option exercise · Warrant to Purchase Common Stock | −801 | 0 | ||
| 2021-01-01 | Gendreau Roger Michael Chief Medical Officer | Grant or award · Stock Option (right to buy) | +41,734 | 41,734 | ||
| 2020-12-21 | Duncan Gregory Scott Chief Executive Officer | Grant or award · Stock Option (right to buy) | +414,125 | 414,125 | ||
| 2020-12-21 | Grosswald Ralph Vice President of Operations | Grant or award · Stock Option (right to buy) | +41,412 | 41,412 | ||
| 2020-12-21 | Walsh Angela VP of Finance | Grant or award · Stock Option (right to buy) | +41,412 | 41,412 | ||
| 2020-12-17 | Pridgen William Director | Purchase | +1,500 | $11.98 | $18K | 727,192 |
Page 6 of 6 · 113 trades